>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Versant Venture Management, LLC Buys Aprea Therapeutics Inc, Flexion Therapeutics Inc, Sells Akero Therapeutics Inc, Veracyte Inc, IVERIC bio Inc

San Francisco, CA, based Investment company Versant Venture Management, LLC (Current Portfolio) buys Aprea Therapeutics Inc, Flexion Therapeutics Inc, sells Akero Therapeutics Inc, Veracyte Inc, IVERIC bio Inc during the 3-months ended 2020Q3, according to the most recent filings of the investment company, Versant Venture Management, LLC. As of 2020Q3, Versant Venture Management, LLC owns 11 stocks with a total value of $546 million. These are the details of the buys and sells.

For the details of Versant Venture Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/versant+venture+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Versant Venture Management, LLC
  1. CRISPR Therapeutics AG (CRSP) - 3,631,656 shares, 55.59% of the total portfolio. Shares reduced by 13.18%
  2. Adverum Biotechnologies Inc (ADVM) - 7,003,892 shares, 13.20% of the total portfolio.
  3. Aprea Therapeutics Inc (APRE) - 1,854,229 shares, 8.17% of the total portfolio. New Position
  4. Flexion Therapeutics Inc (FLXN) - 3,842,578 shares, 7.32% of the total portfolio. New Position
  5. Crinetics Pharmaceuticals Inc (CRNX) - 2,030,616 shares, 5.82% of the total portfolio.
New Purchase: Aprea Therapeutics Inc (APRE)

Versant Venture Management, LLC initiated holding in Aprea Therapeutics Inc. The purchase prices were between $21.66 and $38.86, with an estimated average price of $28.08. The stock is now traded at around $21.39. The impact to a portfolio due to this purchase was 8.17%. The holding were 1,854,229 shares as of .

New Purchase: Flexion Therapeutics Inc (FLXN)

Versant Venture Management, LLC initiated holding in Flexion Therapeutics Inc. The purchase prices were between $10.4 and $13.85, with an estimated average price of $12.27. The stock is now traded at around $11.38. The impact to a portfolio due to this purchase was 7.32%. The holding were 3,842,578 shares as of .

Sold Out: Veracyte Inc (VCYT)

Versant Venture Management, LLC sold out a holding in Veracyte Inc. The sale prices were between $26.73 and $35.67, with an estimated average price of $31.72.

Sold Out: IVERIC bio Inc (ISEE)

Versant Venture Management, LLC sold out a holding in IVERIC bio Inc. The sale prices were between $4.01 and $6.29, with an estimated average price of $4.77.

Reduced: Akero Therapeutics Inc (AKRO)

Versant Venture Management, LLC reduced to a holding in Akero Therapeutics Inc by 63.24%. The sale prices were between $30.79 and $39.92, with an estimated average price of $34.88. The stock is now traded at around $27.90. The impact to a portfolio due to this sale was -5.34%. Versant Venture Management, LLC still held 777,727 shares as of .



Here is the complete portfolio of Versant Venture Management, LLC. Also check out:

1. Versant Venture Management, LLC's Undervalued Stocks
2. Versant Venture Management, LLC's Top Growth Companies, and
3. Versant Venture Management, LLC's High Yield stocks
4. Stocks that Versant Venture Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)